Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi




http://scihub22266oqcxt.onion/
suck pdf from google scholar
19967647!ä!19967647

suck abstract from ncbi


Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid19967647      J+Nephrol 2009 ; 22 (6): 694-8
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Vascular calcification and QT interval in incident hemodialysis patients #MMPMID19967647
  • Di Iorio BR; Cucciniello E; Bellizzi V
  • J Nephrol 2009[Nov]; 22 (6): 694-8 PMID19967647show ga
  • This study proposes [corrected] to evaluate the impact of different phosphate binders on the slowing of [corrected]cardiovascular calcification [corrected] and QT dispersion in incident haemodialysis patients with a follow-up of [corrected] 36 months. This is to be a [corrected] randomized, multicenter, perspective, [corrected] interventional study. Inclusion criteria are age over 18 years and being an [corrected] incident patient [corrected] on hemodialysis. Exclusion criteria are congenital prolongation of QT segment syndrome, QT-c >440 ms, bradycardia <50 beats per minute, symptomatic [corrected] arrhythmia or any other significant heart problems; electrolyte imbalances [corrected] (especially hypokalemia, hypomagnesemia or [corrected] hypocalcemia); abnormal liver function tests and [corrected] hypothyroidism. An informed consent will be taken at study entry. The patients will be randomized to 2 cohorts: [corrected] 180 patients in the sevelamer [corrected] group and 180 patients in calcium-binder phosphate group. Related vascular calcification mortality is the principal end point [corrected] and will be evaluated at 36 months.
  • |Arrhythmias, Cardiac/blood/*drug therapy/etiology[MESH]
  • |Biomarkers/blood[MESH]
  • |Calcinosis/blood/*drug therapy/etiology[MESH]
  • |Calcium/*blood[MESH]
  • |Cardiovascular Diseases/blood/*drug therapy/etiology[MESH]
  • |Chelating Agents/adverse effects/*therapeutic use[MESH]
  • |Electrocardiography[MESH]
  • |Humans[MESH]
  • |Kidney Failure, Chronic/blood/*therapy[MESH]
  • |Phosphates/*blood[MESH]
  • |Polyamines/therapeutic use[MESH]
  • |Prospective Studies[MESH]
  • |Renal Dialysis/*adverse effects[MESH]
  • |Research Design[MESH]
  • |Sevelamer[MESH]
  • |Time Factors[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box